Villepinte (France), March 30, 2021 (6:00 p.m. CET) – Guerbet (FR0000032526 GBT), a global leader in medical imaging, has revealed its Purpose, or Raison d’être: “Build lasting relationships so that we enable people to live better.” A strategic filter and guide for its daily actions.
Since its creation in 1926, Guerbet has placed “human cooperation” at the heart of its relationships and actions with its stakeholders: patients, healthcare professionals, employees, public authorities, partners, shareholders, society and the world.
It establishes relationships based on respect and integrity, to ensure truly value-driven cooperation.
Guerbet thinks of each patient, one of whom benefits every second somewhere in the world from a Guerbet product. The company seeks to make their lives better, through an ever more effective diagnosis or treatment. It wants, in all humility, to be helpful and makes the utmost effort to achieve this goal. Formulating its Purpose will give even greater meaning and clarity to its day-to-day commitments.
This purpose statement will be a driving force for its actions and a source of inspiration for its initiatives and innovations.
“2020 was a sort of eye-opener for us. We focused on two major objectives: first, to protect our employees, and second, business continuity, to carry out our mission as a company in the healthcare field. Identifying and formulating our purpose was an obvious way for us to capture the essence at work during this crisis. Establishing our unique contribution and the impact we want to have on our environment will enable us to overcome all our challenges and achieve sustainable growth,” said David Hale, CEO of Guerbet.
This purpose statement was developed as part of a collaborative process that included employees from all functions and from 11 countries, members of the Executive Committee and the Board of Directors, Guerbet family members, opinion leaders in radiology and other professional partners.
“We are joining the circle of companies that have stated their Purpose. We are living up to our pioneering spirit by uniting with these companies, which are convinced that their activity cannot be considered without taking into account their impact on society. We are embracing this global trend of reinventing the established model. A trend that comes in response to our growing need to find meaning in what we do. All employees, regardless of their job or function, will be able to use it. We will then be guided by an aligned, meaningful, humane, and effective process,” said Claire Durand, Secretary-General of Guerbet.
At Guerbet, we build lasting relationships so that we enable people to live better. This is our purpose. We are a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media with over 2,600 people globally, we are continuously innovating with 10% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020. For more information, please visit www.guerbet.com
+33 (0)6 64 18 99 59